Xian Qiao, MD
Critical Care Medicine · Norfolk, VANPI 1033553664
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $321 of the $370 with a category attached, or 86.7%. 5 manufacturers reported payments, led by AstraZeneca at 34.5% of the total. Reporting peaked in 2022 at $252 and has fallen 72.5% since, to $69 in 2023. That places this record below the midpoint for critical care medicine clinicians in VA, where the typical reported total is $341.
Across 5 payments — averaging $73.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$127
- Intuitive Surgical$99
- United Therapeutics Corporation$69
- La Jolla Pharmaceutical Company$49
- Abiomed$25
Across 6 payments — averaging $11,757 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astrazeneca UK Limited$57K
- Sanofi US Services Inc.$14K
What the payments were for
- Food & beverage$32187%
- Education$4913%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 1 | $127 |
| Intuitive Surgical | 1 | $99 |
| United Therapeutics Corporation | 1 | $69 |
| La Jolla Pharmaceutical Company | 1 | $49 |
| Abiomed | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEZSPIRE$127
How this compares
$370 in reported general payments places this provider in the 50th percentile of 174 critical care medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $654 |
| Pantoprazole Sodium | 18 | $369 |
| Fluticasone Propionate | 19 | $241 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in Norfolk
- Paul MarikNorfolk$23K
- Niall CrowleyNorfolk$905
- Michael EggertNorfolk$870
- Oksana ShlobinFalls Church$375K
- Matthew WilliamsAnnandale$235K
- Sami Abdul JawadFalls Church$193K
- Rajiv MalhotraRichmond$187K
- Thomas BouderWinchester$163K
- Christopher KingFalls Church$131K
- Rohit GoyalFredericksburg$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.